GARY S GILKESON, MD
Osteopathic Medicine at Ashley Ave, Charleston, SC

License number
South Carolina 18479
Category
Osteopathic Medicine
Type
Rheumatology
Address
Address 2
171 Ashley Ave, Charleston, SC 29425
PO Box 751461, Charlotte, NC 28275
Phone
(843) 792-1414
(843) 792-6200

Personal information

See more information about GARY S GILKESON at radaris.com
Name
Address
Phone
Gary Gilkeson
4901 Highgate Dr, Durham, NC 27713
Gary Gilkeson, age 71
843 Whispering Marsh Dr, Charleston, SC 29412
(843) 478-2441
Gary S Gilkeson, age 71
843 Whispering Marsh Dr, Chas, SC 29412
(843) 406-4910
(843) 406-4911

Professional information

Gary S Gilkeson Photo 1

Dr. Gary S Gilkeson, Charleston SC - MD (Doctor of Medicine)

Specialties:
Rheumatology
Address:
MUSC Rheumatology
135 Rutledge St SUITE 503, Charleston 29425
(843) 792-1991 (Phone)
MUSC Rheumatology
96 Jonathan Lucas St SUITE 912, Charleston 29425
(843) 792-1991 (Phone)
MUSE Rheumatology
96 Jonathan Lucas St SUITE 912, Charleston 29425
(843) 876-0500 (Phone)
Medical University of SC RHU
96 Jonathan Lucas St SUITE 912, Charleston 29425
(843) 792-9200 (Phone)
171 Ashley Ave, Charleston 29425
(843) 792-1414 (Phone)
Procedures:
Joint Drainage, Myofascial Trigger Point Injection, Trigger Point Injections, Viscosupplementation With Hyaluronate
Conditions:
Adhesive Capsulitis, Antiphospholipid Syndrome (APS), Arthritis, Behçet's Disease, Bursitis, Carpal Tunnel Syndrome, Chronic Neck Pain, Classic Polyarteritis Nodosa, Degenerative Disc Disease, Dermatomyositis, Enthesopathy of Hip (incl. Trochanteric Bursitis), Fibromyalgia, Giant Cell Arteritis, Gout, Immune Thrombocytopenic Purpura (ITP), Low Back Pain, Lupus Erythematosus, Osteoarthritis, Osteoarthritis of Hand or Wrist, Osteoarthritis of Hip, Osteoarthritis of Knee, Osteoarthritis of Spine, Osteopenia, Osteoporosis, Patellofemoral Pain Syndrome or Knee Pain, Polymyalgia Rheumatica (PMR), Polymyositis, Raynaud's Disease, Reiter's Syndrome (Reactive Arthritis), Rheumatoid Arthritis, Sarcoidosis, Sjögren's Syndrome, Spondylitis, Still's Disease, Systemic Lupus Erythematosus (SLE), Systemic Sclerosis, Systemic Vasculitis, Takayasu's Arteritis, Vasculitis, Wegener's Granulomatosis
Certifications:
Internal Medicine, 1982, Rheumatology, 1988
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
MUSC Rheumatology
135 Rutledge St SUITE 503, Charleston 29425
MUSC Rheumatology
96 Jonathan Lucas St SUITE 912, Charleston 29425
171 Ashley Ave, Charleston 29425
MUSE Rheumatology
96 Jonathan Lucas St SUITE 912, Charleston 29425
Medical University of SC RHU
96 Jonathan Lucas St SUITE 912, Charleston 29425
Musc Medical Center
169 Ashley Ave, Charleston 29425
Education:
Medical School
University Of Texas Southwestern Medical Center At Dallas
Graduated: 1979
U Nc Affil Hosps
Duke University Med Center
University Of Nc Hosps
Duke University Hospital


Gary S Gilkeson Photo 2

Gary S Gilkeson, Charleston SC

Specialties:
Rheumatologist
Address:
171 Ashley Ave, Charleston, SC 29425
Education:
University of Texas, Southwestern Medical School (Dallas) - Doctor of Medicine
Duke University Hospital - Fellowship - Rheumatology (Internal Medicine)
North Carolina Children's Hospital - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Rheumatology (Internal Medicine)


Gary Steven Gilkeson Photo 3

Gary Steven Gilkeson, Charleston SC

Specialties:
Internal Medicine, Rheumatology
Work:
Medical University of South Carolina
96 Jonathan Lucas St, Charleston, SC 29425 Medical University of South Carolina
171 Ashley Ave, Charleston, SC 29425
Education:
The University of Texas Southwestern (1979)


Gary Gilkeson Photo 4

Targeting Complement Factor H For Treatment Of Diseases

US Patent:
7759304, Jul 20, 2010
Filed:
Jun 21, 2007
Appl. No.:
11/821370
Inventors:
Gary Gilkeson - Charleston SC, US
Stephen Tomlinson - Mount Pleasant SC, US
V. Michael Holers - Denver CO, US
Baerbel Rohrer - Mount Pleasant SC, US
Assignee:
Regents of the University of Colorado - Boulder CO
MUSC Foundation For Research Development - Charleston SC
International Classification:
C07K 14/00
US Classification:
514 2, 530350, 4353201, 435325
Abstract:
The invention provides a CR2-FH molecule comprising a CR2 portion comprising CR2 protein or a fragment thereof and a FH portion comprising a factor H protein or a fragment thereof, and pharmaceutical compositions comprising a CR2-FH molecule. Also provided are methods of using the compositions for treatment diseases in which the alternative complement pathway is implicated, such as age-related macular degeneration, rheumatoid arthritis, and ischemia reperfusion.


Gary Gilkeson Photo 5

Anti-Factor B Antibodies

US Patent:
7999082, Aug 16, 2011
Filed:
Feb 10, 2005
Appl. No.:
11/057047
Inventors:
Vernon Michael Holers - Denver CO, US
Joshua M. Thurman - Greenwood Village CO, US
Christian Taube - Denver CO, US
Erwin W. Gelfand - Englewood CO, US
Gary Steven Gilkeson - Charleston SC, US
Assignee:
National Jewish Medical and Research Center - Denver CO
MUSC Foundation for Research Development - Charleston SC
The Regents of the University of Coloraodo - Boulder CO
International Classification:
C07K 16/36, C07K 16/00, A61K 39/395
US Classification:
53038825, 5303871, 5303873, 5303881, 5303882, 4241301, 4241331, 4241411, 4241451, 4241581
Abstract:
Disclosed are novel inhibitors of the alternative complement pathway and particularly, novel anti-factor B antibodies. Also disclosed is the use of such inhibitors to reduce or prevent airway hyperresponsiveness and/or airway inflammation by selectively inhibiting the alternative complement pathway, thereby treating diseases in which such conditions play a role. Also disclosed is the use of such inhibitors to reduce or prevent other diseases and conditions, including ischemia-reperfusion injury, by inhibition of the alternative complement pathway.


Gary Gilkeson Photo 6

Targeting Complement Factor H For Treatment Of Diseases

US Patent:
8569225, Oct 29, 2013
Filed:
May 18, 2010
Appl. No.:
12/782526
Inventors:
Gary Gilkeson - Charleston SC, US
Stephen Tomlinson - Mount Pleasant SC, US
V. Michael Holers - Denver CO, US
Baerbel Rohrer - Mount Pleasant SC, US
Assignee:
MUSC Foundation for Research Development - Charleston SC
The Regents of the University of Colorado, a body corporate - Denver CO
International Classification:
C07K 14/00, C12N 15/00
US Classification:
514 1, 530350, 4353201, 435325
Abstract:
The invention provides a CR2-FH molecule comprising a CR2 portion comprising CR2 protein or a fragment thereof and a FH portion comprising a factor H protein or a fragment thereof, and pharmaceutical compositions comprising a CR2-FH molecule. Also provided are methods of using the compositions for treatment diseases in which the alternative complement pathway is implicated, such as age-related macular degeneration, rheumatoid arthritis, and ischemia reperfusion.


Gary Gilkeson Photo 7

Inhibition Of Factor B, The Alternative Complement Pathway And Methods Related Thereto

US Patent:
2008007, Mar 27, 2008
Filed:
Aug 3, 2007
Appl. No.:
11/888997
Inventors:
Vernon Holers - Denver CO, US
Joshua Thurman - Greenwood Village CO, US
Christian Taube - Denver CO, US
Erwin Gelfand - Englewood CO, US
Gary Gilkeson - Charleston SC, US
International Classification:
C07K 16/46, A61K 39/395, A61P 11/06
US Classification:
424134100, 530391100
Abstract:
Disclosed are novel inhibitors of the alternative complement pathway and particularly, novel anti-factor B antibodies. Also disclosed is the use of such inhibitors to reduce or prevent airway hyperresponsiveness and/or airway inflammation by selectively inhibiting the alternative complement pathway, thereby treating diseases in which such conditions play a role. Also disclosed is the use of such inhibitors to reduce or prevent other diseases and conditions, including ischemia-reperfusion injury, by inhibition of the alternative complement pathway.


Gary Gilkeson Photo 8

Inhibition Of Factor B, The Alternative Complement Pathway And Methods Related Thereto

US Patent:
2008010, May 1, 2008
Filed:
Aug 22, 2007
Appl. No.:
11/843617
Inventors:
V. Holers - Denver CO, US
Joshua Thurman - Greenwood Village CO, US
Christian Taube - Denver CO, US
Erwin Gelfand - Englewood CO, US
Gary Gilkeson - Charleston SC, US
International Classification:
A61K 9/14, A61K 39/395, A61P 11/02
US Classification:
424046000, 424130100
Abstract:
Disclosed are novel inhibitors of the alternative complement pathway and particularly, novel anti-factor B antibodies. Also disclosed is the use of such inhibitors to reduce or prevent airway hyperresponsiveness and/or airway inflammation by selectively inhibiting the alternative complement pathway, thereby treating diseases in which such conditions play a role. Also disclosed is the use of such inhibitors to reduce or prevent other diseases and conditions, including ischemia-reperfusion injury, by inhibition of the alternative complement pathway.